Comfyde carisbamate regulatory update

FDA granted Orphan Drug designation for SK's carisbamate to manage infantile spasms. The oral anticonvulsant is in preclinical testing for the indication. Johnson & Johnson (NYSE:JNJ, New Brunswick, ...